‘Het verschrikkelijkste is dat je niet weet hoe het gaat lopen’

The longest-running population study in the Netherlands – The Rotterdam Study – in the Ommoord district is 35 years old. Professor of Epidemiology and research leader Arfan Ikram is still enthusiastic. The insights from ERGO have led to policy changes in the Netherlands and beyond. ‘It has triggered a change in thinking.’

Researchers at the Erasmus MC Cancer Institute have developed a nationwide database containing a wealth of information on cutaneous squamous cell carcinoma (CSCC). This resource will soon enable doctors to provide more personalized treatments for patients with this type of skin cancer.

Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.